reboxetine has been researched along with Obesity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berezniuk, I; Biswas, R; Creson, TK; Fricker, AD; Fricker, LD; Rodriguiz, RM; Wetsel, WC; Wilkins, JJ | 1 |
| Carson, RE; Ding, YS; Gallezot, JD; Henry, S; Labaree, D; Lee, DE; Li, CS; Nabulsi, N; Neumeister, A; Planeta, B; Potenza, MN; Sinha, R | 1 |
| Bozkurt, H; Şahin, S | 1 |
| Appolinário, JC; Kapczinski, F; Silveira, RO; Zanatto, V | 1 |
1 trial(s) available for reboxetine and Obesity
| Article | Year |
|---|---|
An open trial of reboxetine in obese patients with binge eating disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Bulimia Nervosa; Female; Humans; Morpholines; Obesity; Reboxetine; Treatment Outcome | 2005 |
3 other study(ies) available for reboxetine and Obesity
| Article | Year |
|---|---|
Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) mice.
Topics: Age Factors; Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Carboxypeptidase H; Depression; Diazepam; Exploratory Behavior; Hindlimb Suspension; Maze Learning; Mice; Mice, Transgenic; Morpholines; Motor Activity; Obesity; Point Mutation; Reboxetine; Swimming | 2013 |
Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.
Topics: Adult; Biological Availability; Carbon Radioisotopes; Female; Humans; Male; Morpholines; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Reboxetine; Thalamus; Tissue Distribution | 2014 |
Weight Loss Associated with Reboxetine Use in Adolescents.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Humans; Mental Disorders; Morpholines; Obesity; Reboxetine; Weight Loss | 2016 |